CROMA-PHARMA GmbH
- Country
- 🇦🇹Austria
- Ownership
- Private
- Established
- 1976-01-01
- Employees
- 251
- Market Cap
- -
- Website
- http://www.croma.at
Safety and Effectiveness of THIODERM STRONG in the Correction of Nasolabial Folds
- Conditions
- Correction of Nasolabial Folds
- Interventions
- Device: THIODERM STRONG
- First Posted Date
- 2018-08-28
- Last Posted Date
- 2024-12-09
- Lead Sponsor
- Croma-Pharma GmbH
- Target Recruit Count
- 74
- Registration Number
- NCT03650218
- Locations
- 🇦🇹
Yuvell, Vienna, Austria
🇦🇹Medizinsche Universität Graz-Klinikum für Dermatologie und Venerologie, Graz, Austria
Study of Etafill in Patients With Cataract Surgery Via the Anterior Chamber
- Conditions
- Cataract Surgery
- First Posted Date
- 2018-08-23
- Last Posted Date
- 2024-12-09
- Lead Sponsor
- Croma-Pharma GmbH
- Target Recruit Count
- 60
- Registration Number
- NCT03644862
- Locations
- 🇦🇹
Vienna Institute for Research in Ocular Surgery (VIROS), Hanusch Hospital, Vienna, Austria
Study of Etacoat in Patients With Cataract Surgery Via the Anterior Chamber
- Conditions
- Cataract Surgery
- First Posted Date
- 2018-08-23
- Last Posted Date
- 2024-12-10
- Lead Sponsor
- Croma-Pharma GmbH
- Target Recruit Count
- 40
- Registration Number
- NCT03644875
- Locations
- 🇦🇹
Vienna Institute for Research in Ocular Surgery (VIROS), Hanusch Hospital, Vienna, Austria
Post Market Study Evaluating Princess Filler Lidocaine for the Correction of Nasolabial Folds
- Conditions
- Correction of Nasolabial Folds
- Interventions
- Device: Princess FILLER Lidocaine
- First Posted Date
- 2018-08-02
- Last Posted Date
- 2025-03-18
- Lead Sponsor
- Croma-Pharma GmbH
- Target Recruit Count
- 60
- Registration Number
- NCT03611491
- Locations
- 🇦🇹
MÄZ WIEN Medizinisch Ästhetisches Zentrum Wien, Vienna, Austria
🇦🇹Yuvell, Vienna, Austria
A 52-week Clinical Investigation of Princess® VOLUME PLUS Lidocaine in Subjects With Midface Volume Deficit
- Conditions
- Midface Volume Deficit
- Interventions
- Device: Dermal filler for midface deficit
- First Posted Date
- 2018-05-22
- Last Posted Date
- 2024-12-10
- Lead Sponsor
- Croma-Pharma GmbH
- Target Recruit Count
- 91
- Registration Number
- NCT03532126
- Locations
- 🇩🇪
Rosenpark Research, Darmstadt, Hessen, Germany
🇩🇪RZANY & HUND, Privatpraxis, Berlin, Germany
🇦🇹Medizinisch Ästhetisches Zentrum Wien, Vienna, Austria
Princess® VOLUME Lidocaine for the Correction of Nasolabial Folds
- Conditions
- Nasolabial Fold, Hypoplastic
- Interventions
- Device: Princess® VOLUME Lidocaine
- First Posted Date
- 2017-02-13
- Last Posted Date
- 2018-08-10
- Lead Sponsor
- Croma-Pharma GmbH
- Target Recruit Count
- 60
- Registration Number
- NCT03050710
- Locations
- 🇦🇹
Medical University Graz, Graz, Austria
🇦🇹MÄZ WIEN Medizinisch Ästhetisches Zentrum Wien, Wien, Austria
🇦🇹Ordination Dr. Rudolf Bartsch und Dr. Katrin Bartsch, Wien, Austria
Safety and Performance of Princess® VOLUME for the Treatment of Facial Lipoatrophy, Asymmetry or Scars
- Conditions
- Morphological Asymmetry of the FaceDebilitating ScarsFacial Lipoatrophy
- Interventions
- Device: Princess® VOLUME
- First Posted Date
- 2017-02-13
- Last Posted Date
- 2024-12-09
- Lead Sponsor
- Croma-Pharma GmbH
- Target Recruit Count
- 56
- Registration Number
- NCT03050749
- Locations
- 🇦🇹
MÄZ WIEN Medizinisch Ästhetisches Zentrum Wien, Wien, Austria
🇦🇹Ordination Dr. Benjamin Gehl, Wien, Austria
🇦🇹Medical University Graz, Graz, Austria
Safety and Performance of Princess® FILLER for the Treatment of Facial Lipoatrophy, Asymmetry or Scars
- Conditions
- Facial LipoatrophyMorphological Asymmetry of the FaceDebilitating Scars
- Interventions
- Device: Princess® FILLER
- First Posted Date
- 2017-02-13
- Last Posted Date
- 2024-12-09
- Lead Sponsor
- Croma-Pharma GmbH
- Target Recruit Count
- 53
- Registration Number
- NCT03050723
- Locations
- 🇦🇹
Ordination Dr. Benjamin Gehl, Wien, Austria
🇦🇹Medical University Graz, Graz, Austria
🇦🇹MÄZ WIEN (Medizinisch Ästhetisches Zentrum Wien), Wien, Austria
Botulinum Toxin Treatment of Glabellar Lines: Efficacy and Safety Study II
- Conditions
- Glabellar Frown Lines
- Interventions
- First Posted Date
- 2016-02-09
- Last Posted Date
- 2025-03-19
- Lead Sponsor
- Croma-Pharma GmbH
- Target Recruit Count
- 251
- Registration Number
- NCT02677805
- Locations
- 🇺🇸
California Dermatology & Clinical Research Institute, Encinitas, California, United States
🇺🇸Center for Clinical and Cosmetic Research, Aventura, Florida, United States
🇺🇸Holcomb Kreithen Plastic Surgery, Sarasota, Florida, United States
Botulinum Toxin Treatment of Glabellar Lines: Efficacy and Safety Study I
- First Posted Date
- 2016-02-09
- Last Posted Date
- 2025-03-19
- Lead Sponsor
- Croma-Pharma GmbH
- Target Recruit Count
- 784
- Registration Number
- NCT02677298
- Locations
- 🇺🇸
Maas Clinic, San Francisco, California, United States
🇺🇸Total Skin And Beauty Dermatology Center, Pc, Birmingham, Alabama, United States
🇺🇸About Skin, Greenwood Village, Colorado, United States